Bile acid malabsorption investigated by selenium-75-homocholic acid taurine (75SeHCAT) scans, a retrospective single-centre experience von Vulsteke, F, De Gersem, R, Arts, J, Vanuytsel, T

Volltext

Therapeutic outcome of diverticular associated colitis - a retrospective single centre experience von Vulsteke, F, De Hertogh, G, Vermeire, S

Volltext

Clinical and Molecular Variables Associated With Early Progression to Checkpoint Inhibitors in MSI-High Metastatic Colorectal Cancer: A Retrospective Cohort Study von Hulst, L., Cappuyns, S., Peeters, F., Vulsteke, F., Van Herpe, F., Van Cutsem, E., Dekervel, J.

Volltext

Bile acid malabsorption investigated by selenium-75-homocholic acid taurine (75SeHCAT) scans, a retrospective single-centre experience von Vulsteke, F, De Gersem, R, Arts, J, Vanuytsel, T

Volltext

Therapeutic outcome of diverticular associated colitis - a retrospective single-centre experience von Vulsteke, F, De Hertogh, G, Vermeire, S

Volltext

Clinical and Molecular Variables Associated With Early Progression to Checkpoint Inhibitors in MSI-High Metastatic Colorectal Cancer: A Retrospective Cohort Study von Hulst, L, Cappuyns, S, Peeters, F, Vulsteke, F, Van Herpe, F, Van Cutsem, E, Dekervel, J

Volltext

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, pha... von Coleman, Robert L, Lorusso, Domenica, Gennigens, Christine, González-Martín, Antonio, Randall, Leslie, Cibula, David, Lund, Bente, Woelber, Linn, Pignata, Sandro, Forget, Frederic, Redondo, Andrés, Vindeløv, Signe Diness, Chen, Menghui, Harris, Jeffrey R, Smith, Margaret, Nicacio, Leonardo Viana, Teng, Melinda S L, Laenen, Annouschka, Rangwala, Reshma, Manso, Luis, Mirza, Mansoor, Monk, Bradley J, Vergote, Ignace, Raspagliesi, Francesco, Melichar, Bohuslav, Gaba Garcia, Lydia, Jackson, Amanda, Henry, Stephanie, Kral, Zdenek, Harter, Philipp, De Giorgi, Ugo, Bjurberg, Maria, Gold, Michael, O'Malley, David, Honhon, Brigitte, Vulsteke, Christof, De Cuypere, Eveline, Denys, Hannelore, Baurain, Jean-Francois, Zamagni, Claudio, Tenney, Meaghan, Gordinier, Mary, Bradley, William, Schlumbrecht, Matthew, Spirtos, Nicola, Concin, Nicole, Mahner, Sven, Scambia, Giovanni, Leath, Charles, Farias-Eisner, Robin, Cohen, Joshua, Muller, Carolyn, Bhatia, Sumeet

Volltext

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer von González-Martín, Antonio, Pothuri, Bhavana, Vergote, Ignace, DePont Christensen, René, Graybill, Whitney, Mirza, Mansoor R, McCormick, Colleen, Lorusso, Domenica, Hoskins, Paul, Freyer, Gilles, Baumann, Klaus, Jardon, Kris, Redondo, Andrés, Moore, Richard G, Vulsteke, Christof, O’Cearbhaill, Roisin E, Lund, Bente, Backes, Floor, Barretina-Ginesta, Pilar, Haggerty, Ashley F, Rubio-Pérez, Maria J, Shahin, Mark S, Mangili, Giorgia, Bradley, William H, Bruchim, Ilan, Sun, Kaiming, Malinowska, Izabela A, Li, Yong, Gupta, Divya, Monk, Bradley J

Volltext

Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy von Delombaerde, D., Vervloet, D., Franssen, C., Croes, L., Gremonprez, F., Prenen, H., Peeters, M., Vulsteke, C.

Volltext

Rapidly progressive erosions and ulcerations in a patient with cancer‐associated anti‐TIF‐1γ/α and anti‐U1 RNP‐positive dermatomyositis: A case report von Rosseels, W., Vulsteke, J. B., Bosisio, F., Satoh, M., De Langhe, E., De Haes, P.

Volltext

The genetic basis of natural variation in mushroom body size in Drosophila melanogaster von Zwarts, Liesbeth, Vanden Broeck, Lies, Cappuyns, Elisa, Ayroles, Julien F., Magwire, Michael M., Vulsteke, Veerle, Clements, Jason, Mackay, Trudy F. C., Callaerts, Patrick

Volltext

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial von Monk, B.J., Barretina-Ginesta, M.P., Pothuri, B., Vergote, I., Graybill, W., Mirza, M.R., McCormick, C.C., Lorusso, D., Moore, R.G., Freyer, G., O’Cearbhaill, R.E., Heitz, F., O’Malley, D.M., Redondo, A., Shahin, M.S., Vulsteke, C., Bradley, W.H., Haslund, C.A., Chase, D.M., Pisano, C., Holman, L.L., Pérez, M. J. Rubio, DiSilvestro, P., Gaba, L., Herzog, T.J., Bruchim, I., Compton, N., Shtessel, L., Malinowska, I.A., González-Martín, A.

Volltext

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial von Smith, Matthew R, Scher, Howard I, Sandhu, Shahneen, Efstathiou, Eleni, Lara, Primo N, Yu, Evan Y, Chi, Kim N, Ståhl, Olof, Olmos, David, Danila, Daniel C, Espina, Byron M, Zhao, Xin, Urtishak, Karen A, Francis, Peter, Lopez-Gitlitz, Angela, Parnis, Francis, Horvath, Lisa G., Steer, Christopher, Marx, Gavin, Sandhu, Shahneen, Ferguson, Thomas, Luyten, Daisy, Lumen, Nicolaas, Dirix, Luc, Goeminne, Jean-Charles, Gil, Thierry, Vulsteke, Christof, Kussumoto, Celio, Franke, Fabio A., Martinelli de Oliveira, Fabricio Augusto, Pereira de Santana Gomes, Andrea Juliana, Preto, Daniel D'Almeida, Zucca, Luis Eduardo, Borges, Giuliano Santos, Murad, Andre M., Saad, Fred, Chi, Kim N., Fradet, Yves, Fleshner, Neil E., Emmenegger, Urban, Brasso, Klaus, Culine, Stephane, Thiery-Vuillemin, Antoine, Joly, Florence, Fléchon, Aude, Hilgers, Werner, Borchiellini, Delphine, Barthélémy, Philippe, Berger, Raanan, Mermershtain, Wilmosh, Peer, Avivit, Sella, Avishay, Voortman, Johannes, Aarts, Maureen J., Gietema, Jourik A., Choi, Young-Deuk, Gafanov, Rustem A., Kopyltsov, Evgeniy, Carles, Joan, Mellado, Begoña, Maroto, José Pablo, García-Donás, Jesús, Rodríguez Moreno, Juan Francisco, Durán, Ignacio, Pérez-Valderrama, Begoña, Castro, Elena, Olmos, David, Méndez-Vidal, María José, Muñoz-Langa, José, Herranz, Urbano Anido, Puente Vázquez, Javier, Castellanos, Enrique, Hellström, Martin, Widmark, Anders, Lissbrant, Ingela Franck, Jellvert, Åsa, Külich, Cecilia, Blom, René, Kang, Chih-Hsiung, Ou, Yen-Chuan, Wang, Shian-Shiang, Attard, Gerhardt, Bahl, Amit, Kellati, Prasad, Parikh, Omi, Srinivasan, Rajaguru, Lester, Jason F., Staffurth, John N., Cheng, Heather H., Efstathiou, Eleni, Pilié, Patrick G., George, Daniel J., Karsh, Lawrence I., Kelly, W. Kevin, Danila, Daniel C., Smith, Matthew R., Heath, Elisabeth I., Vaishampayan, Ulka N., Emamekhoo, Hamid, Pinski, Jacek K.

Volltext

433 MANOMETRIC DIAGNOSIS AND TREATMENT OF RETROGRADE CRICOPHARYNGEAL DYSFUNCTION (R-CPD) von Raymenants, Karlien, Vulsteke, Friedel, Arnaert, Stijn, Vanuytsel, Tim, Tack, Jan F., Everaert, Jessie, Baert, Filip J., Delsupehe, Kathelijne, Arts, Joris

Volltext

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial von Siefker-Radtke, A O, Matsubara, N, Park, S H, Huddart, R A, Burgess, E F, Özgüroğlu, M, Valderrama, B P, Laguerre, B, Basso, U, Triantos, S, Akapame, S, Kean, Y, Deprince, K, Mukhopadhyay, S, Loriot, Y

Volltext

2385P Long-term survival upon anti-PD-(L)1 monotherapy in metastatic urothelial cancer (mUC): A multicenter retrospective study von Stockem, C.F., Einerhand, S., Miras Rodriguez, I., Perez Valderrama, B., Vulsteke, C., De Meulenaere, A.M., Morales Barrera, R., Carles Galceran, J., Giannatempo, P., Rametta, A., Bottelli, A., Lefort, F., Bakaloudi, D.R., Talukder, R., Grivas, P., van der Heijden, M.S.

Volltext

LBA9 TROPiCS-04, a randomized phase III study of sacituzumab govitecan (SG) vs chemotherapy (CT) in pretreated advanced urothelial carcinoma (aUC): Overall survival (OS) and safety... von Grivas, P., Powles, T.B., Vulsteke, C., Gross Goupil, M., Park, S.H., Necchi, A., De Santis, M., Duran, I., Morales Barrera, R., Guo, J., Sternberg, C.N., Bellmunt, J., Goebell, P.J., Boateng, F., Sierecki, M., Wang, L., Sima, C., Waldes, J., Tagawa, S.T., Loriot, Y.

Volltext

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ ENGOT-OV26/GOG-3012 trial von Monk, B.J, Barretina-Ginesta, M.P, Pothuri, B, Vergote, I, Graybill, W, Mirza, M.R, Mccormicky, C.C, Lorusso, D, Moore, R.G, Freyer, G, O'Cearbhaill, R.E, Heitz, F, O'Malley, D.M, Redondo, A, Shahin, M.S, Vulsteke, C, Bradley, W.H, Haslund, C.A, Chase, D.M, Pisano, C, Holman, L.L, Perez, M.J. Rubio, Disilvestro, P, Gaba, L, Herzog, T.J, Bruchim, I, Compton, N, Shtessel, L, Malinowska, I.A, Gonzalez-Martin, A

Volltext

530P PRIMA/ENGOT-OV26/GOG-3012 study: Updated long-term PFS and safety von Gonzalez Martin, A.J., Pothuri, B., Vergote, I.B., Graybill, W., Mirza, M.R., Mccormick, C., Lorusso, D., Freyer, G., Backes, F., Baumann, K.H., Redondo Sanchez, A., Moore, R.G., Vulsteke, C., O'Cearbhaill, R.E., Malinowska, I., Shtessel, L., Compton, N., Monk, B.J.

Volltext

Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy von Vulsteke, Christof, Chambers, Setsuko K., Pérez, Maria Jesús Rubio, Chan, John K., Raaschou-Jensen, Nicoline, Zhuo, Ying, Lorusso, Domenica, Herzog, Thomas J., de la Motte Rouge, Thibault, Thomes Pepin, Jessica A., Braicu, Elena Ioana, Chen, Lee-may, Levy, Tally, Barter, James F., Pilar Barretina-Ginesta, M., Joosens, Eric, York, Whitney, Malinowska, Izabela A., González-Martín, Antonio, Monk, Bradley J.

Volltext